Marras C - Search Results

1

Rare neurovascular genetic and imaging markers across neurodegenerative diseases.

Dilliott AA, Berberian SA, Sunderland KM, Binns MA, Zimmer J, Ozzoude M, Scott CJM, Gao F, Lang AE, Breen DP, Tartaglia MC, Tan B, Swartz RH, Rogaeva E, Borrie M, Finger E, Fischer CE, Frank A, Freedman M, Kumar S, Pasternak S, Pollock BG, Rajji TK, Tang-Wai DF, Abrahao A, Turnbull J, Zinman L, Casaubon L, Dowlatshahi D, Hassan A, Mandzia J, Sahlas D, Saposnik G, Grimes D, Marras C, Steeves T, Masellis M, Farhan SMK, Bartha R, Symons S, Hegele RA, Black SE, Ramirez J; ONDRI Investigators. Dilliott AA, et al. Among authors: marras c. Alzheimers Dement. 2023 Dec;19(12):5583-5595. doi: 10.1002/alz.13316. Epub 2023 Jun 5. Alzheimers Dement. 2023. PMID: 37272523

2

Recurrent intracranial hemorrhage due to postpartum cerebral angiopathy: implications for management.

Ursell MR, Marras CL, Farb R, Rowed DW, Black SE, Perry JR. Ursell MR, et al. Among authors: marras cl. Stroke. 1998 Sep;29(9):1995-8. doi: 10.1161/01.str.29.9.1995. Stroke. 1998. PMID: 9731629

3

Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial.

Marras C, Andrews D, Sime E, Lang AE. Marras C, et al. Neurology. 2001 Mar 13;56(5):605-10. doi: 10.1212/wnl.56.5.605. Neurology. 2001. PMID: 11245710 Clinical Trial.

4

69-year-old man with gait disturbance and Parkinsonism.

Marras C, Lang AE, Ang LC, Zijlmans J, Wenning GK. Marras C, et al. Mov Disord. 2001 May;16(3):548-61. doi: 10.1002/mds.1082. Mov Disord. 2001. PMID: 11391758 No abstract available.

5

Predicting motor decline and disability in Parkinson disease: a systematic review.

Marras C, Rochon P, Lang AE. Marras C, et al. Arch Neurol. 2002 Nov;59(11):1724-8. doi: 10.1001/archneur.59.11.1724. Arch Neurol. 2002. PMID: 12433259 Review.

6

Measuring motor complications in clinical trials for early Parkinson's disease.

Marras C, Lang AE. Marras C, et al. J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):143-6. doi: 10.1136/jnnp.74.2.143. J Neurol Neurosurg Psychiatry. 2003. PMID: 12531932 Free PMC article. Review. No abstract available.

7

Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.

Marras C, Lang A, Krahn M, Tomlinson G, Naglie G; Parkinson Study Group. Marras C, et al. Mov Disord. 2004 Jan;19(1):22-8. doi: 10.1002/mds.10642. Mov Disord. 2004. PMID: 14743356 Clinical Trial.

8

Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Lang AE; Parkinson Study Group. Marras C, et al. Neurology. 2005 Jan 11;64(1):87-93. doi: 10.1212/01.WNL.0000148603.44618.19. Neurology. 2005. PMID: 15642909

9

Antipsychotic use in older adults with Parkinson's disease.

Marras C, Kopp A, Qiu F, Lang AE, Sykora K, Shulman KI, Rochon PA. Marras C, et al. Mov Disord. 2007 Feb 15;22(3):319-23. doi: 10.1002/mds.21192. Mov Disord. 2007. PMID: 17149718

10

Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia.

Kishore A, Espay AJ, Marras C, Al-Khairalla T, Arenovich T, Asante A, Miyasaki J, Lang AE. Kishore A, et al. Among authors: marras c. Mov Disord. 2007 Feb 15;22(3):328-33. doi: 10.1002/mds.21238. Mov Disord. 2007. PMID: 17216641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page